Jump to content

2025 Genedata Partner Symposium

March 31–April 1 | Boston, MA, USA

Register

The annual Genedata Partner Symposium is a unique interdisciplinary event at the interface between biopharma R&D and IT. Presentations and discussions will focus on innovative applications and new industry requirements: novel molecular formats (e.g., multispecifics, TCRs, CARs, AAVs, RNA vaccines), advanced screening technologies, MS-based multi-attribute methods (MAM), NGS, molecular patient profiling, and automation and data FAIRification in biopharmaceutical R&D.

At this invitation-only event, leading biopharma companies will show how groups have set up, operate, and use Genedata solutions to transform their biotherapeutics research & development and how this results in increased efficiency and throughput. The symposium brings together people working in all areas of biopharma:

  • Discovery—Screening, selection, engineering, and validation
  • Development—Characterization, optimization, and cell-line engineering
  • Production—Bioprocessing, biosafety, and QC
  • Precision Medicine—Patient profiling and integrative (pre-)clinical research
  • IT—Infrastructure, networking, and integration
  • Automation—Laboratory, data and research process automation

Are You a Genedata Customer? Secure Your Spot for the 2025 Genedata Partner Symposium.

Preliminary Speaker List

Driving Change: Lessons on Successful Global Digital Deployment from Boehringer Ingelheim   
Rachel Kroe-Barrett, Executive Director, Biophysics, Boehringer Ingelheim, Ridgefield, CT, USA 
Towards an Integrated Wet Lab and Dry Lab: Leveraging Genedata
Yves Fomekong Nanfack, Executive Director, Head of End-to-End AI Foundations, Large Molecules Research Platform, Sanofi, Cambridge, MA, USA  
Smart Strategies for Digitalizing Biotherapeutics Discovery at Gilead 
Chung-Ming Hiseh, Vice President Protein Therapeutics, Gilead, Foster City, CA, USA
Navigating the Future: Digitalizing Drug Discovery with Genedata at AstraZeneca
Morris Chen, Target Identification Capability Lead, R&D IT, AstraZeneca, Gaithersburg, MD, USA 
Lessons Learned from a Global Genedata Deployment: Impact on Automation, Novel Modalities, and AI/ML 
Barbara Brannetti, Director, Data Science, Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, USA 
Leveraging Genedata Expressionist to Accelerate Multi Attribute Method by LC-MS Workflows 
Thomas Pohl, Director Analytical Characterization, Novartis, Basel, Switzerland 
AbbVie’s Digitalization Journey with Genedata 
Sukru Kaymakcalan, Director of Information Research and Technology Solutions, AbbVie, Worcester, MA, USA 
Real-Time Monitoring of Batch and Perfusion Process Using In-Line Biocapacitance Measurements 
Tingting Jiang, Associate Principal Scientist, Merck & Co, Kenilworth, NJ, USA 
Genedata @GSK: Impact on Data Science, Analytics, and Lab Automation Workflows 
Przemyslaw Stasica, Biopharma Discovery Data Designer & Thil Batuwangala, Director Data Sciences – Large Molecule Discovery, GSK, Stevenage, United Kingdom 
Sample Directed Automation of Peptide Mapping Data Analysis
Michael E. Pettit, Principal Scientist, Characterization, Analytical Development Biologics, Johnson & Johnson, Malvern, PA, USA 
Sequence Variant Identification via Bottom-up Sequencing 
Michael McKinnon, Scientist II, Novartis, Marblehead, MA, USA 
Biologics Discovery and Engineering at AbbVie Enabled by Genedata Biologics 
Debra Touw, Principal Scientist, Multi-Specifics Biologics, AbbVie, Worcester, MA, USA 
Chemical Liability Screening for Biotherapeutic Proteins — Using a Proteomic Approach and HT Data Analysis to Identify Antibody Chemical Liabilities in Early-Stage Discovery
Xiaohua Liu, Principal Scientist, Sanofi, Cambridge, MA, USA 
Jennifer Kuehn, Lab Head, Assays and Analytics, Sanofi, Frankfurt, Germany 
Leveraging Genedata Screener in AZ Cell Panel Screening Solution  
Ilya Papok, Senior Business Analyst, AstraZeneca, Cambridge, MA, USA 
Unlocking the Potential of Genedata Expressionist in High-Throughput Mass Spec Characterization to Supercharge Biologics Discovery 
Steven Pomerantz, Principal Scientist, Johnson & Johnson, Spring House, PA, USA
Mapping Peptides with Precision
Trina Mouchahoir, Research Chemist, National Institute of Standards and Technology (NIST), Rockville, MD, USA 
Assay Performance Monitoring: An Arvinas Case-Study 
Bassem Shebl, Research Investigator, Arvinas, New Haven, CT, USA
PEPP in Action: High-Throughput Protein Expression and Purification at Sanofi Powered by Genedata
Eva Bric-Furlong, Automation Specialist, Sanofi, Cambridge, MA, USA 
Joel Bard, Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA (Title TBA)
Michael Gallagher, Data Operations Senior Scientist, Johnson & Johnson, Spring House, PA, USA (Title TBA)
Debra Nickischer, Senior IT Capabilities Manager, Arvinas, New Haven, CT, USA (Title TBA)
Hareesh Chandrupatla, Director, Data Science Platforms, Revolution Medicines, Redwood City, CA, USA (Title TBA)
Moderna, Cambridge, CA, USA (Speaker TBA)
Novartis, Basel, Switzerland (Speaker TBA) 

A Roundup of the 2024 Partner Symposium

Hear from Genedata Customers at the 2024 Partner Symposium

AstraZeneca
Janssen
Pfizer
GSK
Sanofi
Novartis
Abbvie
Roche
AstraZeneca
Ferring
Janssen
Novartis
Merck
Daiichi Sankyo
Biotalys
Sartorius
AstraZeneca
UCB
AstraZeneca
Debiopharm
Charles River

Interested in learning more about our last symposium?

See Agenda 2024

Bentley University Conference Center
175 Forest Street
Waltham, MA 02452, USA
+1-781-891-2273
Website
Directions
Please use parking lots A-1 or B-2.

A list of hotels located near Bentley University, where the Partner Symposium will be held.

Register

Having trouble viewing the form? Please contact us by email at symposium(at)genedata.com.